LYNBROOK, N.Y., Oct. 20 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Pink Sheets: BSTC) today announced that Mr. Thomas Wegman, President, will present an overview of the company and it's product pipeline at the 9th Annual Healthcare Conference of Acumen Bio Fin Rodman Renshaw LLC. The presentation will take place on Wednesday November 7, 2007 at 10:10 AM at the New York Palace Hotel in Holmes I.
About BioSpecifics Technologies Corp
BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed and licensed injectable collagenase for three clinical indications. We have a development and licensing agreement with Auxilium Pharmaceuticals for clinical indications in Dupuytren's disease, Peyronie's disease and frozen shoulder (adhesive capsulitis).